{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:20:19Z","timestamp":1787872819400,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55157-w","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T12:13:17Z","timestamp":1781352797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EZH2 as regulator of stemness signature and driver of esophageal squamous cell carcinomas"],"prefix":"10.1038","volume":"16","author":[{"given":"Fatemeh","family":"Nourmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam M.","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajiheh","family":"Zarrinpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7691-6897","authenticated-orcid":false,"given":"Mohammad Mahdi","family":"Forghanifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"55157_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00650-0","volume":"8","author":"X-X Chen","year":"2017","unstructured":"Chen, X.-X. et al. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing. Nat. Commun. 8, 524 (2017).","journal-title":"Nat. Commun."},{"key":"55157_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/dote.12088","volume":"28","author":"J Chen","year":"2015","unstructured":"Chen, J. et al. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Dis. Esophagus. 28, 84\u201389 (2015).","journal-title":"Dis. Esophagus"},{"key":"55157_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1383-5742(00)00019-3","volume":"462","author":"AM Mandard","year":"2000","unstructured":"Mandard, A. M., Hainaut, P. & Hollstein, M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat. Res.\/Rev. Mutat. Res. 462, 335\u2013342 (2000).","journal-title":"Mutat. Res.\/Rev. Mutat. Res."},{"key":"55157_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan, E. et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology 163, 649\u2013658 (2022). e642.","journal-title":"Gastroenterology"},{"key":"55157_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.gastro.2023.05.030","volume":"165","author":"KP Ko","year":"2023","unstructured":"Ko, K. P. et al. Key genetic determinants driving esophageal squamous cell carcinoma initiation and immune evasion. Gastroenterology 165, 613\u2013628 (2023).","journal-title":"Gastroenterology"},{"key":"55157_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.apsb.2021.09.028","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Wang, Y. & Meng, L. Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: new opportunities towards molecularly targeted therapy. Acta Pharm. Sinica B. 12, 1054\u20131067 (2022).","journal-title":"Acta Pharm. Sinica B"},{"key":"55157_CR7","doi-asserted-by":"crossref","unstructured":"Jin, Z. & Zhao, M. Efficacy and safety profile of PD-1 inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: Systematic review and meta-analysis of randomized controlled trials (2022).","DOI":"10.21203\/rs.3.rs-2213352\/v1"},{"key":"55157_CR8","doi-asserted-by":"crossref","unstructured":"Luo, J. et al. Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis (2023).","DOI":"10.21203\/rs.3.rs-2542976\/v1"},{"key":"55157_CR9","doi-asserted-by":"publisher","first-page":"24511","DOI":"10.18632\/oncotarget.4312","volume":"6","author":"AC Li","year":"2015","unstructured":"Li, A. C. et al. Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy. Oncotarget 6, 24511 (2015).","journal-title":"Oncotarget"},{"key":"55157_CR10","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","volume":"33","author":"AW Lee","year":"2015","unstructured":"Lee, A. W., Ma, B. B., Ng, W. T. & Chan, A. T. Management of nasopharyngeal carcinoma: Current practice and future perspective. J. Clin. Oncol. 33, 3356\u20133364 (2015).","journal-title":"J. Clin. Oncol."},{"key":"55157_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11523-017-0508-3","volume":"12","author":"JD Lathia","year":"2017","unstructured":"Lathia, J. D. & Liu, H. Overview of cancer stem cells and stemness for community oncologists. Target. Oncol. 12, 387\u2013399 (2017).","journal-title":"Target. Oncol."},{"key":"55157_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc3597","volume":"13","author":"B Beck","year":"2013","unstructured":"Beck, B. & Blanpain, C. Unravelling cancer stem cell potential. Nat. Rev. Cancer 13, 727\u2013738 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"55157_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1083\/jcb.201202014","volume":"198","author":"I Baccelli","year":"2012","unstructured":"Baccelli, I. & Trumpp, A. The evolving concept of cancer and metastasis stem cells. J. Cell Biol. 198, 281\u2013293 (2012).","journal-title":"J. Cell Biol."},{"key":"55157_CR14","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.celrep.2018.11.035","volume":"25","author":"J Kim","year":"2018","unstructured":"Kim, J. et al. Polycomb-and methylation-independent roles of EZH2 as a transcription activator. Cell Rep. 25, 2808-2820. e2804 (2018).","journal-title":"Cell Rep."},{"key":"55157_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00505-0","volume":"10","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Post-translational modifications of EZH2 in cancer. Cell. bioscience. 10, 1\u201313 (2020).","journal-title":"Cell. bioscience"},{"key":"55157_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/cas.14840","volume":"112","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. The noncanonical role of EZH2 in cancer. Cancer Sci. 112, 1376\u20131382 (2021).","journal-title":"Cancer Sci."},{"key":"55157_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/aps.2013.161","volume":"35","author":"J-z Tan","year":"2014","unstructured":"Tan, J.-z, Yan, Y., Wang, X.-x, Jiang, Y. & Xu, H. E. EZH2: Biology, disease, and structure-based drug discovery. Acta Pharmacol. Sin. 35, 161\u2013174 (2014).","journal-title":"Acta Pharmacol. Sin."},{"key":"55157_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103093","author":"M Titelbaum","year":"2021","unstructured":"Titelbaum, M. et al. Ezh2 harnesses the intranuclear actin cytoskeleton to remodel chromatin in differentiating Th cells. iScience https:\/\/doi.org\/10.1016\/j.isci.2021.103093 (2021).","journal-title":"iScience"},{"key":"55157_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2741\/4760","volume":"24","author":"A Batool","year":"2019","unstructured":"Batool, A., Jin, C. & Liu, Y. X. Role of EZH2 in cell lineage determination and relative signaling pathways. Front. Bioscience-Landmark. 24, 947\u2013960 (2019).","journal-title":"Front. Bioscience-Landmark"},{"key":"55157_CR20","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s12672-025-03634-5","volume":"16","author":"ZR Chen","year":"2025","unstructured":"Chen, Z. R. et al. Identification and analysis of key transcription factors in esophageal squamous cell carcinoma. Discover Oncol. 16, 1810 (2025).","journal-title":"Discover Oncol."},{"key":"55157_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.911285","volume":"12","author":"S Zheng","year":"2022","unstructured":"Zheng, S., Liu, B. & Guan, X. The role of tumor microenvironment in invasion and metastasis of esophageal squamous cell carcinoma. Front. Oncol. 12, 911285 (2022).","journal-title":"Front. Oncol."},{"key":"55157_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23253-2","volume":"12","author":"F Nourmohammadi","year":"2022","unstructured":"Nourmohammadi, F., Forghanifard, M. M., Abbaszadegan, M. R. & Zarrinpour, V. EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas. Sci. Rep. 12, 18290 (2022).","journal-title":"Sci. Rep."},{"key":"55157_CR23","doi-asserted-by":"publisher","first-page":"664816","DOI":"10.3389\/fcell.2021.664816","volume":"9","author":"S Luan","year":"2021","unstructured":"Luan, S. et al. Advances in drug resistance of esophageal cancer: from the perspective of tumor microenvironment. Front. Cell. Dev. Biology. 9, 664816 (2021).","journal-title":"Front. Cell. Dev. Biology"},{"key":"55157_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01709-5","volume":"39","author":"X Jiang","year":"2020","unstructured":"Jiang, X. et al. The role of microenvironment in tumor angiogenesis. J. Exp. Clin. Cancer Res. 39, 1\u201319 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"55157_CR25","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano, R., Ramachandran, M. & Dimberg, A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell. Mol. Life Sci. 77, 1745\u20131770 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"55157_CR26","doi-asserted-by":"crossref","unstructured":"Dong, Y., Alonso, F., Jahjah, T., Fremaux, I. & G\u00e9not, E. Cell Migration in Three Dimensions 345\u2013364 (Springer, 2023).","DOI":"10.1007\/978-1-0716-2887-4_20"},{"key":"55157_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","volume":"100","author":"L Lamalice","year":"2007","unstructured":"Lamalice, L., Le Boeuf, F. & Huot, J. Endothelial cell migration during angiogenesis. Circ. Res. 100, 782\u2013794 (2007).","journal-title":"Circ. Res."},{"key":"55157_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold, M., Soerjomataram, I., Ferlay, J. & Forman, D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64, 381\u2013387 (2015).","journal-title":"Gut"},{"key":"55157_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ng.2935","volume":"46","author":"D-C Lin","year":"2014","unstructured":"Lin, D.-C. et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat. Genet. 46, 467\u2013473 (2014).","journal-title":"Nat. Genet."},{"key":"55157_CR30","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/cancers12082160","volume":"12","author":"G Businello","year":"2020","unstructured":"Businello, G. et al. The pathologic and molecular landscape of esophageal squamous cell carcinogenesis. Cancers 12, 2160 (2020).","journal-title":"Cancers"},{"key":"55157_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02360-2","volume":"10","author":"H Lee","year":"2025","unstructured":"Lee, H. et al. Cancer stem cells: Landscape, challenges and emerging therapeutic innovations. Signal Transduct. Target. Ther. 10, 248 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"55157_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/1354750X.2022.2157875","volume":"28","author":"S Hoque","year":"2023","unstructured":"Hoque, S. et al. Cancer stem cells (CSCs): Key player of radiotherapy resistance and its clinical significance. Biomarkers 28, 139\u2013151 (2023).","journal-title":"Biomarkers"},{"key":"55157_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10555-023-10144-9","volume":"43","author":"H Fatma","year":"2024","unstructured":"Fatma, H. & Siddique, H. R. Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked? Cancer Metastasis Rev. 43, 423\u2013440 (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"55157_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.9734\/jcti\/2024\/v14i1247","volume":"14","author":"JW Sentoso","year":"2024","unstructured":"Sentoso, J. W., Putra, A. & Alif, I. Targeting unique features of quiescent cancer stem cells to overcome resistance and recurrence in cancer therapy: A review. J. Cancer Tumor Int. 14, 18\u201331 (2024).","journal-title":"J. Cancer Tumor Int."},{"key":"55157_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/omi.2020.0185","volume":"25","author":"K Dzobo","year":"2021","unstructured":"Dzobo, K., Ganz, C., Thomford, N. E. & Senthebane, D. A. Cancer stem cell markers in relation to patient survival outcomes: Lessons for integrative diagnostics and next-generation anticancer drug development. Omics 25, 81\u201392 (2021).","journal-title":"Omics"},{"key":"55157_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036905","volume":"10","author":"T Celi\u00e0-Terrassa","year":"2020","unstructured":"Celi\u00e0-Terrassa, T. & Jolly, M. K. Cancer stem cells and epithelial-to-mesenchymal transition in cancer metastasis. Cold Spring Harb. Perspect. Med. 10, a036905 (2020).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"55157_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/cas.14285","volume":"111","author":"Q Quan","year":"2020","unstructured":"Quan, Q. et al. Cancer stem-like cells with hybrid epithelial\/mesenchymal phenotype leading the collective invasion. Cancer Sci. 111, 467\u2013476 (2020).","journal-title":"Cancer Sci."},{"key":"55157_CR38","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2022.20","volume":"5","author":"AR Safa","year":"2022","unstructured":"Safa, A. R. Drug and apoptosis resistance in cancer stem cells: A puzzle with many pieces. Cancer Drug Resist. 5, 850 (2022).","journal-title":"Cancer Drug Resist."},{"key":"55157_CR39","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1158\/1078-0432.CCR-09-2824","volume":"16","author":"CA O'Brien","year":"2010","unstructured":"O\u2019Brien, C. A., Kreso, A. & Jamieson, C. H. Cancer stem cells and self-renewal. Clin. Cancer Res. 16, 3113\u20133120 (2010).","journal-title":"Clin. Cancer Res."},{"key":"55157_CR40","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s00432-021-03703-6","volume":"147","author":"A Prawira","year":"2021","unstructured":"Prawira, A., Le, T. B. U., Ho, R. Z. W. & Huynh, H. Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor. J. Cancer Res. Clin. Oncol. 147, 2955\u20132968 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"55157_CR41","doi-asserted-by":"publisher","first-page":"37974","DOI":"10.18632\/oncotarget.16467","volume":"8","author":"Y Wen","year":"2017","unstructured":"Wen, Y., Cai, J., Hou, Y., Huang, Z. & Wang, Z. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target. Oncotarget 8, 37974 (2017).","journal-title":"Oncotarget"},{"key":"55157_CR42","doi-asserted-by":"publisher","first-page":"41540","DOI":"10.18632\/oncotarget.9236","volume":"7","author":"JF Chen","year":"2016","unstructured":"Chen, J. F. et al. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt\/\u03b2-catenin signaling. Oncotarget 7, 41540 (2016).","journal-title":"Oncotarget"},{"key":"55157_CR43","doi-asserted-by":"publisher","first-page":"637298","DOI":"10.3389\/fonc.2021.637298","volume":"11","author":"JGP Sanches","year":"2021","unstructured":"Sanches, J. G. P. et al. The role of KDM2B and EZH2 in regulating the stemness in colorectal cancer through the PI3K\/AKT pathway. Front. Oncol. 11, 637298 (2021).","journal-title":"Front. Oncol."},{"key":"55157_CR44","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.4161\/15384047.2014.972776","volume":"15","author":"BW Katona","year":"2014","unstructured":"Katona, B. W., Liu, Y., Ma, A., Jin, J. & Hua, X. EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells. Cancer Biol. Ther. 15, 1677\u20131687 (2014).","journal-title":"Cancer Biol. Ther."},{"key":"55157_CR45","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.18632\/oncotarget.14863","volume":"8","author":"I Yamamoto","year":"2017","unstructured":"Yamamoto, I. et al. EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics. Oncotarget 8, 17810 (2017).","journal-title":"Oncotarget"},{"key":"55157_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-013-0516-9","volume":"30","author":"M Moghbeli","year":"2013","unstructured":"Moghbeli, M. et al. Association of PYGO2 and EGFR in esophageal squamous cell carcinoma. Med. Oncol. 30, 1\u20139 (2013).","journal-title":"Med. Oncol."},{"key":"55157_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5416923","author":"LTH Phi","year":"2018","unstructured":"Phi, L. T. H. et al. Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. https:\/\/doi.org\/10.1155\/2018\/5416923 (2018).","journal-title":"Stem Cells Int."},{"key":"55157_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/941876","volume":"2011","author":"R Morrison","year":"2011","unstructured":"Morrison, R. et al. Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J. Oncol. 2011, 941876 (2011).","journal-title":"J. Oncol."},{"key":"55157_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.advms.2022.11.002","volume":"68","author":"SA Khales","year":"2023","unstructured":"Khales, S. A., Forghanifard, M. M., Abbaszadegan, M. R. & Hosseini, S. E. EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma. Adv. Med. Sci. 68, 21\u201330 (2023).","journal-title":"Adv. Med. Sci."},{"key":"55157_CR50","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1158\/0008-5472.CAN-23-2729","volume":"83","author":"S Mukhopadhyay","year":"2023","unstructured":"Mukhopadhyay, S. et al. Genome-wide CRISPR screens identify multiple synthetic lethal targets that enhance KRASG12C inhibitor efficacy. Cancer. Res. 83, 4095\u20134111 (2023).","journal-title":"Cancer. Res."},{"key":"55157_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.178535","volume":"9","author":"W Yang","year":"2024","unstructured":"Yang, W. et al. YAP\/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5\/mTOR axis. JCI. Insight. 9, e178535 (2024).","journal-title":"JCI. Insight."},{"key":"55157_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.852383","volume":"12","author":"Q Luo","year":"2022","unstructured":"Luo, Q. et al. PI3K\/Akt\/mTOR signaling pathway: Role in esophageal squamous cell carcinoma, regulatory mechanisms and opportunities for targeted therapy. Front. Oncol. 12, 852383 (2022).","journal-title":"Front. Oncol."},{"key":"55157_CR53","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1158\/0008-5472.CAN-10-1933","volume":"71","author":"ME Gonzalez","year":"2011","unstructured":"Gonzalez, M. E. et al. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. Cancer Res. 71, 2360\u20132370 (2011).","journal-title":"Cancer Res."},{"key":"55157_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ijc.32285","volume":"145","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo. Int. J. Cancer. 145, 1007\u20131019 (2019).","journal-title":"Int. J. Cancer."},{"key":"55157_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-015-0212-z","volume":"34","author":"Z Zhu","year":"2015","unstructured":"Zhu, Z. et al. Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 34, 1\u20138 (2015).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"55157_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.835","volume":"12","author":"H Xing","year":"2022","unstructured":"Xing, H. et al. Genome-wide gain\u2010of\u2010function screening identifies EZH2 mediating resistance to PI3K\u03b1 inhibitors in oesophageal squamous cell carcinoma. Clin. Transl. Med. 12, e835 (2022).","journal-title":"Clin. Transl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55157-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:06:55Z","timestamp":1787872015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55157-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55157"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55157-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Da.C.,\u00a0Islamic Azad University, and the Ethical Committee (Approval ID: IR.IAU.DAMGHAN.REC.1401.024) (\n                      \n                      ).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of their individual details and accompanying images in this manuscript.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All listed authors consent to the submission.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27008"}}